Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
The global Biological Indicators market was valued at US$ 366.6 million in 2023 and is anticipated to reach US$ 550.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
Report Scope
The Biological Indicators market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Indicators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Indicators companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Segment by Type
Segment by Application
Consumption by Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Indicators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Indicators Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Self-Contained Biological Indicator
1.2.3 Biological Indicator Strip
1.3 Market by Application
1.3.1 Global Biological Indicators Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Indicators Market Perspective (2019-2030)
2.2 Biological Indicators Growth Trends by Region
2.2.1 Global Biological Indicators Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biological Indicators Historic Market Size by Region (2019-2024)
2.2.3 Biological Indicators Forecasted Market Size by Region (2025-2030)
2.3 Biological Indicators Market Dynamics
2.3.1 Biological Indicators Industry Trends
2.3.2 Biological Indicators Market Drivers
2.3.3 Biological Indicators Market Challenges
2.3.4 Biological Indicators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Indicators Players by Revenue
3.1.1 Global Top Biological Indicators Players by Revenue (2019-2024)
3.1.2 Global Biological Indicators Revenue Market Share by Players (2019-2024)
3.2 Global Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biological Indicators Revenue
3.4 Global Biological Indicators Market Concentration Ratio
3.4.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Indicators Revenue in 2023
3.5 Biological Indicators Key Players Head office and Area Served
3.6 Key Players Biological Indicators Product Solution and Service
3.7 Date of Enter into Biological Indicators Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Indicators Breakdown Data by Type
4.1 Global Biological Indicators Historic Market Size by Type (2019-2024)
4.2 Global Biological Indicators Forecasted Market Size by Type (2025-2030)
5 Biological Indicators Breakdown Data by Application
5.1 Global Biological Indicators Historic Market Size by Application (2019-2024)
5.2 Global Biological Indicators Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biological Indicators Market Size (2019-2030)
6.2 North America Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biological Indicators Market Size by Country (2019-2024)
6.4 North America Biological Indicators Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Indicators Market Size (2019-2030)
7.2 Europe Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biological Indicators Market Size by Country (2019-2024)
7.4 Europe Biological Indicators Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Indicators Market Size (2019-2030)
8.2 Asia-Pacific Biological Indicators Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biological Indicators Market Size by Region (2019-2024)
8.4 Asia-Pacific Biological Indicators Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Indicators Market Size (2019-2030)
9.2 Latin America Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biological Indicators Market Size by Country (2019-2024)
9.4 Latin America Biological Indicators Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Indicators Market Size (2019-2030)
10.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biological Indicators Market Size by Country (2019-2024)
10.4 Middle East & Africa Biological Indicators Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Detail
11.1.2 3M Business Overview
11.1.3 3M Biological Indicators Introduction
11.1.4 3M Revenue in Biological Indicators Business (2019-2024)
11.1.5 3M Recent Development
11.2 Getinge Group
11.2.1 Getinge Group Company Detail
11.2.2 Getinge Group Business Overview
11.2.3 Getinge Group Biological Indicators Introduction
11.2.4 Getinge Group Revenue in Biological Indicators Business (2019-2024)
11.2.5 Getinge Group Recent Development
11.3 Cantel Medical
11.3.1 Cantel Medical Company Detail
11.3.2 Cantel Medical Business Overview
11.3.3 Cantel Medical Biological Indicators Introduction
11.3.4 Cantel Medical Revenue in Biological Indicators Business (2019-2024)
11.3.5 Cantel Medical Recent Development
11.4 Mesa Laboratories
11.4.1 Mesa Laboratories Company Detail
11.4.2 Mesa Laboratories Business Overview
11.4.3 Mesa Laboratories Biological Indicators Introduction
11.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2019-2024)
11.4.5 Mesa Laboratories Recent Development
11.5 Steris
11.5.1 Steris Company Detail
11.5.2 Steris Business Overview
11.5.3 Steris Biological Indicators Introduction
11.5.4 Steris Revenue in Biological Indicators Business (2019-2024)
11.5.5 Steris Recent Development
11.6 Fuze Medical
11.6.1 Fuze Medical Company Detail
11.6.2 Fuze Medical Business Overview
11.6.3 Fuze Medical Biological Indicators Introduction
11.6.4 Fuze Medical Revenue in Biological Indicators Business (2019-2024)
11.6.5 Fuze Medical Recent Development
11.7 Matachana
11.7.1 Matachana Company Detail
11.7.2 Matachana Business Overview
11.7.3 Matachana Biological Indicators Introduction
11.7.4 Matachana Revenue in Biological Indicators Business (2019-2024)
11.7.5 Matachana Recent Development
11.8 Hu-Friedy
11.8.1 Hu-Friedy Company Detail
11.8.2 Hu-Friedy Business Overview
11.8.3 Hu-Friedy Biological Indicators Introduction
11.8.4 Hu-Friedy Revenue in Biological Indicators Business (2019-2024)
11.8.5 Hu-Friedy Recent Development
11.9 Advanced Sterilization
11.9.1 Advanced Sterilization Company Detail
11.9.2 Advanced Sterilization Business Overview
11.9.3 Advanced Sterilization Biological Indicators Introduction
11.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2019-2024)
11.9.5 Advanced Sterilization Recent Development
11.10 Bag Health Care
11.10.1 Bag Health Care Company Detail
11.10.2 Bag Health Care Business Overview
11.10.3 Bag Health Care Biological Indicators Introduction
11.10.4 Bag Health Care Revenue in Biological Indicators Business (2019-2024)
11.10.5 Bag Health Care Recent Development
11.11 Terragene
11.11.1 Terragene Company Detail
11.11.2 Terragene Business Overview
11.11.3 Terragene Biological Indicators Introduction
11.11.4 Terragene Revenue in Biological Indicators Business (2019-2024)
11.11.5 Terragene Recent Development
11.12 Andersen
11.12.1 Andersen Company Detail
11.12.2 Andersen Business Overview
11.12.3 Andersen Biological Indicators Introduction
11.12.4 Andersen Revenue in Biological Indicators Business (2019-2024)
11.12.5 Andersen Recent Development
11.13 GKE
11.13.1 GKE Company Detail
11.13.2 GKE Business Overview
11.13.3 GKE Biological Indicators Introduction
11.13.4 GKE Revenue in Biological Indicators Business (2019-2024)
11.13.5 GKE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research